Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma
Titel:
Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma
Auteur:
Jansen, Y.J.L. Rozeman, E.A. Mason, R. Goldinger, S.M. Geukes Foppen, M.H. Hoejberg, L. Schmidt, H. van Thienen, J.V. Haanen, J.B.A.G. Tiainen, L. Svane, I.M. Mäkelä, S. Seremet, T. Arance, A. Dummer, R. Bastholt, L. Nyakas, M. Straume, O. Menzies, A.M. Long, G.V. Atkinson, V. Blank, C.U. Neyns, B.